S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
South Korean doctors hold massive anti-government rally over medical school recruitment plan
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
South Korean doctors hold massive anti-government rally over medical school recruitment plan
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
South Korean doctors hold massive anti-government rally over medical school recruitment plan
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
South Korean doctors hold massive anti-government rally over medical school recruitment plan
NASDAQ:EVOK

Evoke Pharma (EVOK) Stock Price, News & Analysis

$0.65
-0.01 (-1.52%)
(As of 03/1/2024 ET)
Today's Range
$0.57
$0.67
50-Day Range
$0.62
$1.15
52-Week Range
$0.56
$3.70
Volume
26,827 shs
Average Volume
52,670 shs
Market Capitalization
$2.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

EVOK stock logo

About Evoke Pharma Stock (NASDAQ:EVOK)

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

EVOK Stock Price History

EVOK Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Evoke Pharma Inc (EVOK)
EVOKE PHARMA INC.DL-,0001 (EV00.DU)
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
StockNews.com Initiates Coverage on Evoke Pharma (NASDAQ:EVOK)
Evoke Pharma Inc
Evoke Pharma Announces Pricing of Recent Offering
Evoke Pharma Prices Public Offering Of Up To $30 Mln Of Shares
Ben Beckley Joins RevHealth As CEO
Evoke Pharma Inc EVOK
See More Headlines
Receive EVOK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evoke Pharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/21/2023
Today
3/02/2024
Next Earnings (Estimated)
3/19/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:EVOK
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Net Income
$-8,220,000.00
Net Margins
-176.93%
Pretax Margin
-176.93%

Debt

Sales & Book Value

Annual Sales
$4.30 million
Book Value
$1.22 per share

Miscellaneous

Free Float
2,949,000
Market Cap
$2.17 million
Optionable
Not Optionable
Beta
0.21
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. David A. Gonyer R.Ph. (Age 60)
    Co-Founder, CEO & Director
    Comp: $806.53k
  • Mr. Matthew J. D'Onofrio MBA (Age 54)
    Co-Founder, President, COO, Secretary & Treasurer
    Comp: $557.11k
  • Dr. Marilyn R. Carlson (Age 76)
    Chief Medical Officer
    Comp: $518.14k
  • Mr. Christopher Quesenberry
    Chief Commercial Officer - Gimoti (TM)














EVOK Stock Analysis - Frequently Asked Questions

How have EVOK shares performed in 2024?

Evoke Pharma's stock was trading at $1.0503 at the beginning of the year. Since then, EVOK stock has decreased by 38.1% and is now trading at $0.65.
View the best growth stocks for 2024 here
.

Are investors shorting Evoke Pharma?

Evoke Pharma saw a decrease in short interest during the month of February. As of February 15th, there was short interest totaling 219,800 shares, a decrease of 46.1% from the January 31st total of 407,900 shares. Based on an average trading volume of 51,400 shares, the short-interest ratio is presently 4.3 days. Currently, 2.7% of the company's shares are short sold.
View Evoke Pharma's Short Interest
.

When is Evoke Pharma's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 19th 2024.
View our EVOK earnings forecast
.

How were Evoke Pharma's earnings last quarter?

Evoke Pharma, Inc. (NASDAQ:EVOK) posted its quarterly earnings results on Tuesday, March, 21st. The specialty pharmaceutical company reported ($0.53) earnings per share for the quarter. The specialty pharmaceutical company had revenue of $0.80 million for the quarter. Evoke Pharma had a negative net margin of 176.93% and a negative trailing twelve-month return on equity of 517.99%.

When did Evoke Pharma's stock split?

Shares of Evoke Pharma reverse split on Monday, May 23rd 2022. The 1-12 reverse split was announced on Monday, May 23rd 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, May 23rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

What other stocks do shareholders of Evoke Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Evoke Pharma investors own include Bank of Hawaii (BOH), InterDigital (IDCC), STAG Industrial (STAG), Advanced Micro Devices (AMD), Novavax (NVAX), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Pfizer (PFE), Gilead Sciences (GILD) and Bed Bath & Beyond (BBBY).

Who are Evoke Pharma's major shareholders?

Evoke Pharma's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%).
View institutional ownership trends
.

How do I buy shares of Evoke Pharma?

Shares of EVOK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:EVOK) was last updated on 3/3/2024 by MarketBeat.com Staff